139 related articles for article (PubMed ID: 29061672)
21. Senescence-associated microRNAs target cell cycle regulatory genes in normal human lung fibroblasts.
Markopoulos GS; Roupakia E; Tokamani M; Vartholomatos G; Tzavaras T; Hatziapostolou M; Fackelmayer FO; Sandaltzopoulos R; Polytarchou C; Kolettas E
Exp Gerontol; 2017 Oct; 96():110-122. PubMed ID: 28658612
[TBL] [Abstract][Full Text] [Related]
22. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
23. miR-101 inhibits the G1-to-S phase transition of cervical cancer cells by targeting Fos.
Liang X; Liu Y; Zeng L; Yu C; Hu Z; Zhou Q; Yang Z
Int J Gynecol Cancer; 2014 Sep; 24(7):1165-72. PubMed ID: 24987920
[TBL] [Abstract][Full Text] [Related]
24. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
25. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
[TBL] [Abstract][Full Text] [Related]
26. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
[TBL] [Abstract][Full Text] [Related]
27. Novel miR-5582-5p functions as a tumor suppressor by inducing apoptosis and cell cycle arrest in cancer cells through direct targeting of GAB1, SHC1, and CDK2.
An HJ; Kwak SY; Yoo JO; Kim JS; Bae IH; Park MJ; Cho MY; Kim J; Han YH
Biochim Biophys Acta; 2016 Oct; 1862(10):1926-37. PubMed ID: 27475256
[TBL] [Abstract][Full Text] [Related]
28. [Antisense to CDK4 inhibits the growth of human colon cancer cells HT29].
Ye YJ; Zhu XG; Wang S; Wang YC; Sang JL
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):846-9. PubMed ID: 16681978
[TBL] [Abstract][Full Text] [Related]
29. Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.
Pathak S; Meng WJ; Nandy SK; Ping J; Bisgin A; Helmfors L; Waldmann P; Sun XF
Oncotarget; 2015 Dec; 6(42):44758-80. PubMed ID: 26556872
[TBL] [Abstract][Full Text] [Related]
30. Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
Hossian AKMN; Sajib MS; Tullar PE; Mikelis CM; Mattheolabakis G
Sci Rep; 2018 Jul; 8(1):10495. PubMed ID: 30002440
[TBL] [Abstract][Full Text] [Related]
31. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
Zhang X; Zhang Y; Yang J; Li S; Chen J
Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136
[TBL] [Abstract][Full Text] [Related]
33. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
34. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
36. miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma.
Xiao H; Xiao W; Cao J; Li H; Guan W; Guo X; Chen K; Zheng T; Ye Z; Wang J; Xu H
Cancer Lett; 2016 Apr; 374(1):107-116. PubMed ID: 26808577
[TBL] [Abstract][Full Text] [Related]
37. MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
Wang L; Shi M; Hou S; Ding B; Liu L; Ji X; Zhang J; Deng Y
FEBS Lett; 2012 May; 586(9):1312-7. PubMed ID: 22465663
[TBL] [Abstract][Full Text] [Related]
38. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
39. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.
Al-Haidari AA; Syk I; Thorlacius H
Oncotarget; 2017 Feb; 8(9):14887-14896. PubMed ID: 28146427
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
